Abstract:Epigenetic gene regulations can be considered as de-novo initiation of abnormal molecular signaling events whose regulation is otherwise required during normal or specific developmental stages of the organisms. Primarily, three different mechanisms have been identified to participate in epigenetic gene regulations which include, DNA methylation, non-coding RNA species (microRNAs [miRNA], and long non-coding RNAs [LNC-RNA]) and histone modifications. These de-novo epigenetic mechanisms have been associated with altered normal cellular functions which eventually facilitate normal cells to transition into an abnormal phenotype. Among the three modes of regulation, RNA species which are usually considered to be less stable, can be speculated to initiate instant alterations in gene expression compared to DNA methylation or histone modifications. However, LNC-RNAs appear to be more stable in the cells than the other RNA species. Moreover, there is increasing literature which clearly suggests that a single specific LNC-RNA can regulate multiple mechanisms and disease phenotypes. With specific focus on cardiovascular diseases, here we attempt to provide UpToDate information on the functional role of miRNAs and LNC-RNAs. Here we discuss the role of these epigenetic mediators in different components of cardiovascular disease which include physiopathological heart development, athersclerosis, retenosis, diabetic hearts, myocardial infarction, ischemia-reperfusion, heart valve disease, aortic aneurysm, osteogenesis, angiogenesis and hypoxia in the heart. While there is abundant literature support that shows the involvement of many LNC-RNAs and miRNAs in cardiovascular diseases, very few RNA species have been identified which regulate epigenetic mechanisms which is the current focus in this article. Understanding the role of these RNA species in regulating epigenetic mechanisms in different cell types causing cardiovascular disease, would advance the field and promote disease prevention approaches that are aimed to target epigenetic mechanisms.

Modulating the Expression of Exercise-induced lncRNAs: Implications for Cardiovascular Disease Progression

Long Non-Coding RNAs in Cardiovascular Diseases: Potential Function as Biomarkers and Therapeutic Targets of Exercise Training

Recent advances on the roles of LncRNAs in cardiovascular disease

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases

The relationship between long non-coding RNA and cardiovascular development and diseases

LncRNA-encoded peptides: unveiling their significance in cardiovascular physiology and pathology-current research insights

Lncrnas As Therapeutic Targets For Autophagy-Involved Cardiovascular Diseases: A Review Of Molecular Mechanism And Therapy Strategy

LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases

Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function

Evaluation of Lncrna Expression Pattern and Potential Role in Heart Failure Pathology

Beyond the silence: A comprehensive exploration of long non-coding RNAs as genetic whispers and their essential regulatory functions in cardiovascular disorders

LncRNA: An Important Regulator of Atherosclerosis

Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseases

Exercise training maintains cardiovascular health: signaling pathways involved and potential therapeutics

[Lncrnas and Cardiovascular Diseases].

Advances in Intercellular Communication Mediated by Exosomal Ncrnas in Cardiovascular Disease

Effects of MicroRNAs and Long Non-coding RNAs on Beneficial Action of Exercise on Cognition in Degenerative Diseases: A Review

Exercise for the Heart: Signaling Pathways

The Emerging Roles of Long Noncoding RNAs in Common Cardiovascular Diseases

The Role of Selected lncRNAs in Lipid Metabolism and Cardiovascular Disease Risk